Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines
Vaccines form the cornerstone of any control, eradication and preventative strategy and this is no different for lumpy skin disease. However, the usefulness of a vaccine is determined by a multiplicity of factors which include stability, efficiency, safety and ease of use, to name a few. Although th...
Main Authors: | Andy Haegeman, Ilse De Leeuw, Laurent Mostin, Willem Van Campe, Laetitia Aerts, Estelle Venter, Eeva Tuppurainen, Claude Saegerman, Kris De Clercq |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/5/473 |
Similar Items
-
Duration of Immunity Induced after Vaccination of Cattle with a Live Attenuated or Inactivated Lumpy Skin Disease Virus Vaccine
by: Andy Haegeman, et al.
Published: (2023-01-01) -
The Importance of Quality Control of LSDV Live Attenuated Vaccines for Its Safe Application in the Field
by: Andy Haegeman, et al.
Published: (2021-09-01) -
Detection of Clinical and Subclinical Lumpy Skin Disease Using Ear Notch Testing and Skin Biopsies
by: Laetitia Aerts, et al.
Published: (2021-10-01) -
Recombinant LSDV Strains in Asia: Vaccine Spillover or Natural Emergence?
by: Frank Vandenbussche, et al.
Published: (2022-06-01) -
Review: Vaccines and Vaccination against Lumpy Skin Disease
by: Eeva Tuppurainen, et al.
Published: (2021-10-01)